Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature Immunology

• Publication date

  2017-07-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ni.3800PMID 28759001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lineages

  2018cited by this paper
• Bench to bedside: NK cells and control of metastasis.

  2017cited by this paper
• A distinct innate lymphoid cell population regulates tumor-associated T cells

  2017cited by this paper
• SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling

  2017cited by this paper
• Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression

  2016cited by this paper
• Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.

  2016cited by this paper
• Transforming growth factor–β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells

  2016cited by this paper
• NK cells and type 1 innate lymphoid cells: partners in host defense

  2016cited by this paper
• Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.

  2016cited by this paper
• Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage

  2016cited by this paper
• Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells.

  2016cited by this paper
• TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

  2016cited by this paper
• ILC1s in Tissue Inflammation and Infection

  2016cited by this paper
• CIS is a potent checkpoint in NK cell–mediated tumor immunity

  2016cited by this paper
• Targeting natural killer cells in cancer immunotherapy

  2016cited by this paper
• Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer

  2015cited by this paper
• A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1.

  2015cited by this paper
• Innate Lymphoid Cells in Cancer

  2015cited by this paper
• NK cells and cancer: you can teach innate cells new tricks

  2015cited by this paper
• The Molecular Signatures Database (MSigDB) hallmark gene set collection.

  2015cited by this paper
• Characterization of tumor infiltrating Natural Killer cell subset

  2015cited by this paper
• Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer

  2015cited by this paper
• Composition, Development, and Function of Uterine Innate Lymphoid Cells

  2015cited by this paper
• Transcriptional Programs Define Molecular Characteristics of Innate Lymphoid Cell Classes and Subsets

  2015cited by this paper
• NK cells require IL-28R for optimal in vivo activity

  2015cited by this paper
• The Molecular Signatures Database Hallmark Gene Set Collection

  2015cited by this paper
• Differentiation and diversity of subsets in group 1 innate lymphoid cells.

  2015cited by this paper
• Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs

  2015cited by this paper
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015cited by this paper
• TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells

  2014cited by this paper
• A committed hemopoietic precursor to innate lymphoid cells

  2014cited by this paper
• Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

  2014cited by this paper
• Ly49 receptors activate angiogenic mouse DBA+ uterine natural killer cells

  2014cited by this paper
• Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma

  2014cited by this paper
• Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.

  2014cited by this paper
• Leukocyte driven-decidual angiogenesis in early pregnancy

  2014cited by this paper
• Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells

  2014cited by this paper
• voom: precision weights unlock linear model analysis tools for RNA-seq read counts

  2014cited by this paper
• Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells

  2014cited by this paper
• Differential Requirement for Nfil3 during NK Cell Development

  2014cited by this paper
• Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.

  2013cited by this paper
• The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.

  2013cited by this paper
• Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

  2013cited by this paper
• Phase I clinical trial combining imatinib mesylate and IL-2

  2013cited by this paper
• The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote

  2013cited by this paper
• Targeting the TGFβ signalling pathway in disease

  2012cited by this paper
• Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.

  2012cited by this paper
• Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity

  2011cited by this paper
• Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor

  2011cited by this paper
• TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

  2010cited by this paper
• Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression

  2010cited by this paper
• Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody

  2009cited by this paper
• Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.

  2009cited by this paper
• TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice.

  2009cited by this paper
• Tumour necrosis factor and cancer

  2009cited by this paper
• TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype.

  2008cited by this paper
• Inferring Pathway Activity toward Precise Disease Classification

  2008cited by this paper
• TGFβ promotes conversion of CD16+ peripheral blood NK cells into CD16− NK cells with similarities to decidual NK cells

  2007cited by this paper
• Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy

  2007cited by this paper
• CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer1

  2006cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• The roles of IFNγ in protection against tumor development and cancer immunoediting

  2002cited by this paper
• IFN-γ–mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide

  2002cited by this paper
• IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide.

  2002cited by this paper
• The roles of IFN gamma in protection against tumor development and cancer immunoediting.

  2002cited by this paper
• NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

  2001cited by this paper
• NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

  2001cited by this paper
• Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells

  2000cited by this paper
• Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

  1993cited by this paper
• Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.

  1991cited by this paper

• Mechanisms and strategies for reversing NK cell exhaustion in tumor immunotherapy.

  2026cites this paper
• Decoding innate lymphoid cell heterogeneity and plasticity in colorectal cancer

  2026cites this paper
• Innate lymphoid cells as emerging players in cancer immunotherapy

  2026cites this paper
• Prolonged TGF-β locks NK cells in a dysfunctional state through persistent epigenetic remodeling of IRF, T-bet and EOMES binding sites

  2026influential citation
• Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy.

  2026cites this paper
• TGF-β in tumor development and progression: mechanisms and therapeutics

  2026cites this paper
• Mechanotransduction of Piezo1 in the cancer microenvironment: implications for NK cell-based immunotherapy

  2026cites this paper
• Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications

  2025cites this paper
• Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors.

  2025cites this paper
• Exploring the Tumor Microenvironment in Osteosarcoma: Driver of Resistance and Progression

  2025cites this paper
• Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression

  2025cites this paper
• “Dissecting the role of T cell exhaustion in cancer progression: a multifaceted approach“

  2025cites this paper
• Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL

  2025cites this paper
• Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers

  2025cites this paper
• EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis

  2025cites this paper
• Innate Lymphoid Cells in Pancreatic Ductal Adenocarcinoma: Immune Regulation and Therapeutic Implications.

  2025cites this paper
• Adjusting the scope of natural killer cells in cancer therapy

  2025cites this paper
• Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets

  2025cites this paper
• Immunomodulatory Mechanisms of ILC2 in Lung Development: Emerging Insights Into Bronchopulmonary Dysplasia Pathogenesis

  2025cites this paper
• CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

  2025cites this paper
• Prospects and limitations of NK cell adoptive therapy in clinical applications

  2025cites this paper
• IL-15 functionalized biomimetic hybrid mRNA vaccine for enhanced NSCLC immunotherapy via synergistic activation of T cells and NK cells

  2025cites this paper
• Eomesodermin defines uterine NK cells crucial for pregnancy success in mice

  2025cites this paper
• NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity

  2025cites this paper
• Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression

  2025cites this paper
• Mitochondrial genetics defines anti-tumour immunity through mitochondrial ROS and PD-1 signalling

  2025cites this paper
• Immunological Interventions in Bacterial Infections: From Mechanisms to Clinical Applications

  2025cites this paper
• Tissue localization of natural killer cells dictates surveillance of lung metastasis

  2025cites this paper
• Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances

  2025cites this paper
• A novel subset of inflammation-related liver NK cells modulates immune responses in a murine model of primary biliary cholangitis.

  2025cites this paper
• Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features

  2025influential citation
• TGF-β drives the conversion of conventional NK cells into uterine tissue-resident NK cells to support murine pregnancy

  2025cites this paper
• NK cell adaptation in the tumor microenvironment: Insights for NK cell-based immunotherapy.

  2025cites this paper
• Profiling tumour-infiltrating immune cells in a large paediatric medulloblastoma cohort: a retrospective analysis

  2025cites this paper
• The diversity of natural killer cell functional and phenotypic states in cancer

  2025cites this paper
• Natural killer cell infiltration elicits gender‐dependent dichotomous clinical outcomes in urothelial carcinoma

  2025cites this paper
• Ferroptosis and its relationship with cancer

  2025cites this paper
• Advances in augmenting infiltration of active natural killer cells into pediatric and adult solid tumors

  2025cites this paper
• Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy

  2025cites this paper
• Helper ILCs in the human hematopoietic system.

  2025cites this paper
• The Potential Mechanisms of Extracellular Vesicles in Transfusion-Related Adverse Reactions: Recent Advances.

  2025cites this paper
• The role of innate immune cells in modulating vascular dynamics in skin malignancies.

  2025cites this paper
• NK cell activity in the tumor microenvironment

  2025cites this paper
• Rescuing natural killer cells from the cancer wilderness

  2025cites this paper
• Innate Lymphoid Cells: Dual Roles and Therapeutic Opportunities in Breast Cancer.

  2025cites this paper
• Modeling the Transitional Phase of Epithelial Cells Reveals Prognostic and Therapeutic Targets in Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Innate lymphoid cells in the spotlight: from biomarkers to blueprint for innovative immunotherapy

  2025cites this paper
• Cxcr3 promotes protection from colorectal cancer liver metastasis by driving NK cell infiltration and plasticity

  2025cites this paper
• A membrane lipid signature unravels the dynamic landscape of group 1 innate lymphoid cells across the health-disease continuum

  2025cites this paper
• CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment

  2025cites this paper
• The multifaceted role of YAP in the tumor microenvironment and its therapeutic implications in cancer

  2025cites this paper
• Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumors

  2025cites this paper
• Diverse Landscape of Group 1 Innate Lymphoid Cells Predicts the Prognosis in Patients with Head and Neck Squamous Cell Carcinoma

  2025cites this paper
• Innate lymphoid cells, immune functional dynamics, epithelial parallels, and therapeutic frontiers in infections

  2025cites this paper
• Cytokine-driven cancer immune evasion mechanisms.

  2025cites this paper
• Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy.

  2025cites this paper
• Innate Lymphoid Cells.

  2025cites this paper
• The role of coinhibitory receptor-expressing non-T cells in inflammation and immunity: unsung heroes or peripheral players?

  2025cites this paper
• Transforming Growth Factor‐Beta Signaling in Cancer: Therapeutic Implications, Challenges, and Pathways to Progress

  2025cites this paper
• Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications

  2025cites this paper
• Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity.

  2024cites this paper
• Eomes expression identifies the early bone marrow precursor to classical NK cells

  2024cites this paper
• Dissecting the Heterogeneity and Tumor-Associated Dynamics of Human Liver Group I ILC via scRNA Sequencing Data

  2024cites this paper
• An emerging maestro of immune regulation: how DOT1L orchestrates the harmonies of the immune system

  2024cites this paper
• Decoding changes in tumor‐infiltrating leukocytes through dynamic experimental models and single‐cell technologies

  2024cites this paper
• DOT1L maintains NK cell phenotype and function for optimal tumor control.

  2024cites this paper
• DNA demethylase Tet2 promotes the terminal maturation of natural killer cells

  2024cites this paper
• Dietary vitamin D3 supplementation enhances splenic NK cell activity in healthy and diabetic male mice.

  2024cites this paper
• Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy

  2024cites this paper
• Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors

  2024cites this paper
• The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance

  2024cites this paper
• Hypoxic tumor microenvironment: Destroyer of natural killer cell function.

  2024cites this paper
• From biology to the clinic — exploring liver metastasis in prostate cancer

  2024cites this paper
• Generation of an Inhibitory NK Cell Subset by TGF-β1/IL-15 Polarization.

  2024cites this paper
• Tissue-specific features of innate lymphoid cells in antiviral defense

  2024cites this paper
• Challenges and opportunities for cancer stem cell‐targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell‐dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes

  2024cites this paper
• Metabolic programming of organ‐specific natural killer cell responses

  2024cites this paper
• Cancer immunity by tissue‐resident type 1 innate lymphoid cells and killer innate‐like T cells

  2024cites this paper
• Emerging roles of type 1 innate lymphoid cells in tumour pathogenesis and cancer immunotherapy

  2024cites this paper
• Multilayered Immunity by Tissue-Resident Lymphocytes in Cancer.

  2024cites this paper
• Control of the Development, Distribution, and Function of Innate-Like Lymphocytes and Innate Lymphoid Cells by the Tissue Microenvironment.

  2024cites this paper
• Innate Lymphoid Cells and Their Role in the Immune Response to Infections

  2024cites this paper
• Implications of innate lymphoid cells in oral diseases.

  2024cites this paper
• TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer

  2024cites this paper
• Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy

  2024cites this paper
• Type 1 immunity enables neonatal thymic ILC1 production

  2024cites this paper
• NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer

  2024cites this paper
• Prophylactic treatment with Bacteroides uniformis and Bifidobacterium bifidum counteracts hepatic NK cell immune tolerance in nonalcoholic steatohepatitis induced by high fat diet

  2024cites this paper
• Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity

  2024cites this paper
• Prdm1 positively regulates liver Group 1 ILCs cancer immune surveillance and preserves functional heterogeneity

  2024cites this paper
• Tumor-Infiltrating Immune Cells in Colorectal Cancer

  2024cites this paper
• Low-Dose Eribulin Promotes NK Cell-Mediated Therapeutic Efficacy in Bladder Cancer

  2024cites this paper
• Inositol phosphatase INPP4B sustains ILC1s and intratumoral NK cells through an AKT-driven pathway

  2024cites this paper
• Natural killer cell-mediated immune surveillance in cancer: Role of tumor microenvironment.

  2024cites this paper
• Autocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cells

  2024cites this paper
• Single cell profiling of hematopoietic stem cell transplant recipients reveals TGF-β1 and IL-2 confer immunoregulatory functions to NK cells

  2024cites this paper
• Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1

  2024cites this paper
• Natural killer cell therapies

  2024cites this paper
• People are an organic unity: Gut-lung axis and pneumonia

  2024cites this paper
• Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammation

  2024cites this paper